Hepatic arterial infusion of autologous CD34 ⁺ cells for hepatitis C virus-related decompensated cirrhosis: A multicenter, open-label, exploratory randomized controlled trial.

Autor: Nakamura T; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Fukuoka, 8300011, Japan.; Liver Cancer Research Division, Research Center for Innovative Cancer Therapy, Kurume University, Kurume, Fukuoka, 8300011, Japan., Masuda A; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Fukuoka, 8300011, Japan.; Liver Cancer Research Division, Research Center for Innovative Cancer Therapy, Kurume University, Kurume, Fukuoka, 8300011, Japan., Kako M; Gastroenterology Medicine Center, Shonan Kamakura General Hospital, Kamakura, Kanagawa, 2478533, Japan., Enomoto H; Division of Hepatobiliary and Pancreatic Diseases, Department of Gastroenterology, Hyogo Medical University, Nishinomiya, Hyogo, 6638501, Japan., Kaibori M; Department of Surgery, Kansai Medical University, 2-5-1 Shinmachi, Hirakata, 5731191, Japan., Fujita Y; Translational Research Center for Medical Innovation, Foundation for Biomedical Research and Innovation at Kobe, Kobe, Hyogo, 6500047, Japan., Tanizawa K; Translational Research Center for Medical Innovation, Foundation for Biomedical Research and Innovation at Kobe, Kobe, Hyogo, 6500047, Japan., Ioji T; Translational Research Center for Medical Innovation, Foundation for Biomedical Research and Innovation at Kobe, Kobe, Hyogo, 6500047, Japan., Fujimori Y; Department of Transfusion Medicine and Cellular Therapy, Hyogo Medical University, Nishinomiya, Hyogo, 6638501, Japan., Fukami K; Division of Nephrology, Department of Medicine, Kurume University School of Medicine, Kurume, Fukuoka, 8300011, Japan., Hazama T; Division of Nephrology, Department of Medicine, Kurume University School of Medicine, Kurume, Fukuoka, 8300011, Japan., Iwamoto H; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Fukuoka, 8300011, Japan.; Liver Cancer Research Division, Research Center for Innovative Cancer Therapy, Kurume University, Kurume, Fukuoka, 8300011, Japan., Kako Y; Department of Radiology, Hyogo Medical University, Nishinomiya, Hyogo, 6638501, Japan., Kobayashi K; Department of Radiology, Hyogo Medical University, Nishinomiya, Hyogo, 6638501, Japan.; Department of Radiology, Kawanishi City Medical Center, Kawanishi, 6660017, Japan., Koga H; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Fukuoka, 8300011, Japan.; Liver Cancer Research Division, Research Center for Innovative Cancer Therapy, Kurume University, Kurume, Fukuoka, 8300011, Japan., Nagafuji K; Division of Hematology and Oncology, Department of Medicine, Kurume University School of Medicine, Kurume, Fukuoka, 8300011, Japan., Ohtake T; Department of Regenerative Medicine, The Center for Cell Therapy & Regenerative Medicine, Shonan Kamakura General Hospital, Kamakura, Kanagawa, 2478533, Japan., Suzuki H; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Fukuoka, 8300011, Japan.; Liver Cancer Research Division, Research Center for Innovative Cancer Therapy, Kurume University, Kurume, Fukuoka, 8300011, Japan., Takashima T; Division of Hepatobiliary and Pancreatic Diseases, Department of Gastroenterology, Hyogo Medical University, Nishinomiya, Hyogo, 6638501, Japan., Tsukiyama T; Department of Radiology and Interventional Radiology, Shonan Kamakura General Hospital, Kamakura, Kanagawa, 2478533, Japan., Uojima H; Gastroenterology Medicine Center, Shonan Kamakura General Hospital, Kamakura, Kanagawa, 2478533, Japan.; Department of Genome Medical Sciences Project, Research Institute, National Center for Global Health and Medicine, Ichikawa, Chiba, 2728516, Japan., Yamahara K; Laboratory of Molecular and Cellular Therapy, Institute for Advanced Medical Sciences, Hyogo Medical University, Nishinomiya, Hyogo, 6638501, Japan., Yamakado K; Department of Radiology, Hyogo Medical University, Nishinomiya, Hyogo, 6638501, Japan., Yamamoto H; Department of Surgery, Kansai Medical University, 2-5-1 Shinmachi, Hirakata, 5731191, Japan., Yoh K; Division of Hepatobiliary and Pancreatic Diseases, Department of Gastroenterology, Hyogo Medical University, Nishinomiya, Hyogo, 6638501, Japan.; Yoh Digestive Clinic, Wakayama, 6408269, Japan., Yoshihara S; Department of Transfusion Medicine and Cellular Therapy, Hyogo Medical University, Nishinomiya, Hyogo, 6638501, Japan., Kawamoto A; Translational Research Center for Medical Innovation, Foundation for Biomedical Research and Innovation at Kobe, Kobe, Hyogo, 6500047, Japan., Nishiguchi S; Division of Hepatobiliary and Pancreatic Diseases, Department of Gastroenterology, Hyogo Medical University, Nishinomiya, Hyogo, 6638501, Japan.; Department of Gastroenterology, Kano General Hospital, Osaka, Japan, 5310041, Japan., Kobayashi S; Department of Kidney Disease and Transplant Center, Shonan Kamakura General Hospital, Kamakura, Kanagawa, 2478533, Japan., Torimura T; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Fukuoka, 8300011, Japan.; Department of Gastroenterology, Omuta City Hospital, Omuta, 8368567, Japan., Kawaguchi T; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Fukuoka, 8300011, Japan.

Publikováno v: Regenerative therapy [Regen Ther] 2024 May 04; Vol. 27, pp. 455-463. Date of Electronic Publication: 2024 May 04 (Print Publication: 2024).

Phase II study of the efficacy and safety of lenvatinib for anaplastic thyroid cancer (HOPE).

Autor: Higashiyama T; Department of Surgery, Kuma Hospital, Kobe, Japan. Electronic address: higashiyama@kuma-h.or.jp., Sugino K; Department of Surgery, Ito Hospital, Tokyo, Japan., Hara H; Department of Breast and Endocrine Surgery, Tsukuba University, Tsukuba, Japan., Ito KI; Division of Breast and Endocrine Surgery, Department of Surgery, Shinshu University School of Medicine, Matsumoto, Japan., Nakashima N; Division of Surgical Oncology, Graduate School of Medicine, Tohoku University, Sendai, Japan., Onoda N; Department of Surgery, Kuma Hospital, Kobe, Japan; Department of Breast & Endocrine Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan., Tori M; Department of Endocrine Surgery, Osaka Police Hospital, Osaka, Japan., Katoh H; Department of Breast and Endocrine Surgery, Kitasato University School of Medicine, Sagamihara, Japan., Kiyota N; Oncology/Hematology, Kobe University Hospital Cancer Center, Kobe, Japan., Ota I; Nara Medical University, Kashihara, Japan., Suganuma N; Kanagawa Cancer Center, Yokohama, Japan., Hibi Y; Fujita Health University Hospital, Toyoake, Japan., Nemoto T; Department of Otorhinolaryngology, Japanese Red Cross Narita Hospital, Chiba, Japan., Takahashi S; Department of Medical Oncology, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan., Yane K; Department of Otolaryngology-Head and Neck Surgery, Kindai University Nara Hospital, Ikoma, Japan., Ioji T; Translational Research Center for Medical Innovation, Kobe, Japan., Kojima S; Translational Research Center for Medical Innovation, Kobe, Japan., Kaneda H; Translational Research Center for Medical Innovation, Kobe, Japan., Sugitani I; Department of Endocrine Surgery, Nippon Medical School, Tokyo, Japan., Tahara M; Department of Head and Neck Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan.

Publikováno v: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2022 Sep; Vol. 173, pp. 210-218. Date of Electronic Publication: 2022 Aug 03.

Autologous Granulocyte Colony-Stimulating Factor-Mobilized Peripheral Blood CD34 Positive Cell Transplantation for Hemodialysis Patients with Critical Limb Ischemia: A Prospective Phase II Clinical Trial.

Autor: Ohtake T; Department of Kidney Disease and Transplant Center, Shonan Kamakura General Hospital, Kamakura, Japan.; Division of Regenerative Medicine, Department of Center for Clinical and Translational Science, Shonan Kamakura General Hospital, Kamakura, Japan., Mochida Y; Department of Kidney Disease and Transplant Center, Shonan Kamakura General Hospital, Kamakura, Japan., Ishioka K; Department of Kidney Disease and Transplant Center, Shonan Kamakura General Hospital, Kamakura, Japan., Oka M; Department of Kidney Disease and Transplant Center, Shonan Kamakura General Hospital, Kamakura, Japan., Maesato K; Department of Kidney Disease and Transplant Center, Shonan Kamakura General Hospital, Kamakura, Japan., Moriya H; Department of Kidney Disease and Transplant Center, Shonan Kamakura General Hospital, Kamakura, Japan., Hidaka S; Department of Kidney Disease and Transplant Center, Shonan Kamakura General Hospital, Kamakura, Japan., Higashide S; Translational Research Informatics Center, Foundation for Biomedical Research and Innovation, Kobe, Japan., Ioji T; Translational Research Informatics Center, Foundation for Biomedical Research and Innovation, Kobe, Japan., Fujita Y; Translational Research Informatics Center, Foundation for Biomedical Research and Innovation, Kobe, Japan., Kawamoto A; Translational Research Informatics Center, Foundation for Biomedical Research and Innovation, Kobe, Japan., Fukushima M; Translational Research Informatics Center, Foundation for Biomedical Research and Innovation, Kobe, Japan., Kobayashi S; Department of Kidney Disease and Transplant Center, Shonan Kamakura General Hospital, Kamakura, Japan.; Division of Regenerative Medicine, Department of Center for Clinical and Translational Science, Shonan Kamakura General Hospital, Kamakura, Japan.

Publikováno v: Stem cells translational medicine [Stem Cells Transl Med] 2018 Nov; Vol. 7 (11), pp. 774-782. Date of Electronic Publication: 2018 Jul 30.

Optical Frequency Domain Imaging Versus Intravascular Ultrasound in Percutaneous Coronary Intervention (OPINION Trial): Results From the OPINION Imaging Study.

Autor: Otake H; Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan., Kubo T; Department of Cardiovascular Medicine, Wakayama Medical University, Wakayama, Japan., Takahashi H; Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan., Shinke T; Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan., Okamura T; Division of Cardiology, Department of Medicine and Clinical Science, Yamaguchi University Graduate School of Medicine, Ube, Japan., Hibi K; Division of Cardiology, Yokohama City University Medical Center, Yokohama, Japan., Nakazawa G; Division of Cardiology, Tokai University School of Medicine, Isehara, Japan., Morino Y; Division of Cardiology, Iwate Medical University, Morioka, Japan., Shite J; Division of Cardiology, Osaka Saiseikai Nakatsu Hospital, Osaka, Japan., Fusazaki T; Division of Cardiology, Iwate Medical University, Morioka, Japan., Kozuma K; Division of Cardiology, Teikyo University School of Medicine, Tokyo, Japan., Ioji T; Translational Research Informatics Center, Kobe, Japan., Kaneda H; Translational Research Informatics Center, Kobe, Japan., Akasaka T; Department of Cardiovascular Medicine, Wakayama Medical University, Wakayama, Japan. Electronic address: akasat@wakayama-med.ac.jp.

Publikováno v: JACC. Cardiovascular imaging [JACC Cardiovasc Imaging] 2018 Jan; Vol. 11 (1), pp. 111-123. Date of Electronic Publication: 2017 Oct 05.

Evaluation of prognostic significance of granulocyte-related factors in cancer patients undergoing personalized peptide vaccination.

Autor: Sakamoto S; a Research Center for Innovative Cancer Therapy; Kurume University ; Kurume , Japan.; b Cancer Vaccine Center; Kurume University ; Kurume , Japan.; c Department of Molecular and Internal Medicine ; Institute of Biomedical & Health Sciences; Hiroshima University ; Hiroshima , Japan., Yoshitomi M; d Department of Surgery ; Kurume University School of Medicine ; Kurume , Japan., Yutani S; b Cancer Vaccine Center; Kurume University ; Kurume , Japan., Terazaki Y; d Department of Surgery ; Kurume University School of Medicine ; Kurume , Japan., Yoshiyama K; d Department of Surgery ; Kurume University School of Medicine ; Kurume , Japan., Ioji T; b Cancer Vaccine Center; Kurume University ; Kurume , Japan., Matsueda S; b Cancer Vaccine Center; Kurume University ; Kurume , Japan., Yamada A; a Research Center for Innovative Cancer Therapy; Kurume University ; Kurume , Japan., Takamori S; d Department of Surgery ; Kurume University School of Medicine ; Kurume , Japan., Itoh K; b Cancer Vaccine Center; Kurume University ; Kurume , Japan., Hattori N; c Department of Molecular and Internal Medicine ; Institute of Biomedical & Health Sciences; Hiroshima University ; Hiroshima , Japan., Kohno N; c Department of Molecular and Internal Medicine ; Institute of Biomedical & Health Sciences; Hiroshima University ; Hiroshima , Japan., Sasada T; b Cancer Vaccine Center; Kurume University ; Kurume , Japan.; e Kanagawa Cancer Center Research Institute ; Yokohama , Japan.

Publikováno v: Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2015; Vol. 11 (12), pp. 2784-9.